What is the primary purpose of evaluating a chronic disease screening program?

• A. To determine packaging color.
• B. To measure only test sensitivity.
• C. To assess effectiveness, balance benefits and harms, feasibility, and cost-effectiveness, and determine target populations.
• D. To improve marketing strategies for the program.

Answer: (C)

Evaluating a chronic disease screening program aims to judge its overall value for population health by looking at what it actually achieves and what it costs, not just a single test metric. The best answer reflects this broader assessment: it considers how effective the program is, weighs the benefits against potential harms (like false positives or overdiagnosis), checks whether the program can be implemented feasibly in real-world settings, evaluates cost-effectiveness to ensure resources are used wisely, and identifies who should be targeted to maximize benefit.

This holistic approach is essential because screening can lead to earlier detection and treatment but also to harms and resource use that may not be justified in all groups. Simply focusing on the test's sensitivity or on unrelated aspects like packaging or marketing would miss these critical dimensions.